The only difference of course being Ken Waggoner is at the helm now, the treatment is surrounded by the best of the best in the industry now, the FDA has met with Ken Waggoner PharmaCyte Biotech now, so as you can see... it's a much different story here now. But thanks for the old news that is no longer relevant now that Ken Waggoner is the CEO and has taken this further than many would like to have seen.
News 
Market Data 
Discover 
